Remicade (Infliximab)

Brand Remicade is manufactured in the United States and shipped by courier from our pharmacy in India.

Remicade contains the chemical ingredient called infliximab, which is a monoclonal antibody.  Infliximab targets and attaches to TNF alfa in the body, it is thus called a TNF blocker.  By targeting TNF alfa, Remicade reduces the body's inflammation.

Remicade is used by adults for the treatment of inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and psoriasis.

Information about Remicade (Infliximab)

Remicade is a biologic medication containing infliximab as its active ingredient. It is a monoclonal antibody that works by targeting and blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which plays a key role in causing inflammation in various autoimmune conditions. Remicade is administered through intravenous infusion and is typically used to treat conditions such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis, among others. It is used to reduce inflammation, improve symptoms, and prevent further joint or tissue damage caused by autoimmune diseases.

Product Highlights

• Remicade is used in combination with methotrexate to treat moderate to severe rheumatoid arthritis in adults.
• It is used to treat moderate to severe Crohn's disease in adults and children, helping to reduce inflammation in the gastrointestinal tract.
• Remicade is used to treat moderate to severe ulcerative colitis, a chronic inflammatory bowel disease, in both adults and pediatric patients. 
• Used to treat ankylosing spondylitis, a type of arthritis that affects the spine and sacroiliac joints.
• It is also indicated for treating psoriatic arthritis, an autoimmune disease that affects joints and skin.
• Remicade is used to treat moderate to severe plaque psoriasis in adult patients. 

Key Ingredient

• Infliximab

Key Benefits

• Remicade is used to treat a wide range of autoimmune conditions, reducing inflammation and symptoms.
• It helps improve symptoms such as joint pain, stiffness, and gastrointestinal discomfort, enhancing patients' quality of life.
• In rheumatoid arthritis, it can prevent further joint damage and deformities caused by the disease.
• Regular infusions help provide long-term control of symptoms and disease progression in chronic conditions.
• As a well-established TNF inhibitor, Remicade has been proven effective in clinical studies and real-world use for treating autoimmune diseases.

Direction of Use

• Remicade is given via an intravenous (IV) infusion by a healthcare provider. The typical infusion duration is 2 hours, but this can vary.
• The dosing schedule is based on the specific condition being treated. For rheumatoid arthritis, Crohn's disease, and ulcerative colitis, the usual dosing schedule starts with infusions at weeks 0, 2, and 6, followed by maintenance infusions every 8 weeks.
• Patients may need to take pre-medications, such as antihistamines or corticosteroids, to reduce the risk of infusion reactions.
• Maintenance doses are typically administered every 6 to 8 weeks, though the frequency may vary depending on the patient's response.

Safety Concerns

• As a TNF-alpha inhibitor, Remicade can weaken the immune system, making patients more susceptible to serious infections, including tuberculosis (TB), fungal infections, and opportunistic infections.
• Some patients may experience reactions during or after the infusion, including fever, chills, and rash.
• There may be an increased risk of certain cancers, such as lymphoma, in patients receiving TNF inhibitors like Remicade.
• Remicade should be used with caution in patients with heart failure, as it can worsen this condition.
• Liver problems, including hepatitis, can occur in some patients, so regular liver function monitoring is recommended.
• Patients with a history of central nervous system demyelinating disorders (e.g., multiple sclerosis) should use caution when taking Remicade.

Avoid Remicade (Infliximab) If

• Avoid Remicade if you have an active infection, such as tuberculosis, or if you are at risk of infections that cannot be controlled.
• Do not take Remicade if you are allergic to infliximab or any of the other ingredients in the medication.
• Remicade is contraindicated in patients with severe heart failure (NYHA class III/IV).
• Patients with active hepatitis B should avoid Remicade due to the risk of reactivation of the virus.
• Avoid use if you have severe liver disease, as it can increase the risk of liver toxicity.
• Patients with a history of demyelinating diseases (e.g., multiple sclerosis) should avoid Remicade due to potential worsening of symptoms.

This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.